Retatrutide 50mg

Retatrutide 50 mg – Triple Hormone Receptor Agonist for Advanced Metabolic Research

Retatrutide 50 mg is a high-purity, research-grade peptide designed to act as a triple agonist, simultaneously targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This advanced mechanism of action allows for a comprehensive exploration of metabolic regulation, making it an invaluable tool in preclinical research on obesity, type 2 diabetes, and energy balance.

Retatrutide 50mg, The 50 mg formulation provides researchers with a higher-dose option for extended or high-volume studies, enabling detailed investigations into dose-dependent responses, pharmacokinetics, and long-term metabolic effects.

Key Features: Retatrutide 50mg 

• Triple receptor activation for synergistic metabolic effects

• High-dose 50 mg lyophilized peptide for flexibility in dosing

• Ideal for studies involving weight loss, insulin resistance, and appetite control

• Synthesized to ≥98% purity (HPLC verified)

• Stable lyophilized format for long-term storage and easy reconstitution

Applications:

• Obesity and fat metabolism studies

• Type 2 diabetes and glucose regulation research

• Appetite suppression and satiety signaling

• Preclinical evaluation of multi-agonist peptide therapies

Product Details:

• Name: Retatrutide

• Dosage: 50 mg

• Form: Lyophilized powder

• Purity: ≥98%

• Storage: -20°C, protected from light and moisture

• Reconstitution: Sterile water or appropriate buffer.